Can contingency management help people with psychosis give up cannabis? The CIRCLE trial

ben-sweet-2LowviVHZ-E-unsplash

Ian Hamilton summarises the recently published CIRCLE trial, which looks at the clinical and cost-effectiveness of contingency management for cannabis use in early psychosis.

[read the full story...]

Cognitive functioning in psychosis: is neuropsychological decline continuous, generalised, and specific to schizophrenia?

shutterstock_1466819675

Emmeline Lagunes Cordoba and Derek Tracy explore a case control study that looks at cognitive change in people with schizophrenia and other psychoses in the decade following the first episode.

[read the full story...]

Psychosis during ADHD treatment with methylphenidate or amphetamines

seth-macey-cA0HHP94NH4-unsplash

Samuele Cortese reports on a recent study of 13-25 year old people with ADHD, which looks at the comparative risk of psychosis during treatment with methylphenidate and amphetamines.

[read the full story...]

Long term recovery and resilience in psychosis: the iHOPE-20 study

shutterstock_137307233

A group of UCL Mental Health Masters students summarise the iHOPE-20 study, which looks at relationships between and prospective predictors of remission, clinical recovery, personal recovery and resilience 20 years on from a first episode psychosis.

[read the full story...]

How can digital technology help close the mortality gap for people with severe mental illness?

shutterstock_134284016

Lina Gega from the Closing the Gap Network explores a recent review of digital technology for health promotion, which looks at opportunities to address excess mortality in people living with severe mental illness.

[read the full story...]

Continuity of care: a luxury or need?

anastasia-vityukova-1325166-unsplash

LucÍa Almazán Sánchez and Derek Tracy appraise a new paper in the British Journal of Psychiatry on continuity of care and clinical outcomes in the community for people with severe mental illness.

[read the full story...]

Daily skunk cannabis use associated with a 5-fold increase in psychosis risk

lexscope-388938-unsplash

Luke Sheridan-Reins explores a recent paper on the contribution of cannabis use to variation in the incidence of psychotic disorder across Europe.

[read the full story...]

Rates of psychotic disorders: huge variability and important risk factors

jaime-lopes-1303988-unsplash

Emma O’Neill summarises a systematic review and meta-analysis of the incidence of psychotic disorders, which looks at the distribution of rates and the influence of gender, urbanicity, immigration and socio-economic level.

[read the full story...]

Smoking cessation for people with severe mental illness? “Oh yes they can!” SCIMITAR+

stop-4036139_1280

David Shiers and Peter Byrne summarise the new SCIMITAR+ trial out today in The Lancet Psychiatry, which evaluates a bespoke smoking cessation intervention for people with severe mental illness.

[read the full story...]

Is self-management ready for the mental health mainstream?

2985206462_d819f602af_b

Josefien Breedvelt and Peter Coventry explore a new systematic review and meta-analysis of self-management interventions for people with severe mental illness.

[read the full story...]